DALLAS, Feb. 26 – Transferring growth factor genes into the heart appears safe and shows promise for treating the debilitating chest pain known as angina, according to a report in today’s rapid access issue of Circulation: Journal of the American Heart Association.
The above story is based on materials provided by American Heart Association. Note: Materials may be edited for content and length.
Cite This Page:
American Heart Association. "Gene Therapy To Treat Angina Appears Safe." ScienceDaily. ScienceDaily, 26 February 2002. <www.sciencedaily.com/releases/2002/02/020226075329.htm>.
American Heart Association. (2002, February 26). Gene Therapy To Treat Angina Appears Safe. ScienceDaily. Retrieved April 18, 2014 from www.sciencedaily.com/releases/2002/02/020226075329.htm
American Heart Association. "Gene Therapy To Treat Angina Appears Safe." ScienceDaily. www.sciencedaily.com/releases/2002/02/020226075329.htm (accessed April 18, 2014).